Open AccessPharmacological treatments for patients with irritable bowel syndrome
Author(s) -
Qianqian Di,
Ling Yue,
Bin Xue,
Min Chen,
Tai-Chun Tang,
Hui Zheng
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000015920
Subject(s) - medicine , irritable bowel syndrome , medline , cochrane library , systematic review , evidence based medicine , psychological intervention , randomized controlled trial , alternative medicine , publication bias , medical literature , intensive care medicine , meta analysis , physical therapy , psychiatry , pathology , political science , law
Several pharmacological treatments are beneficial for patients with irritable bowel syndrome (IBS), and there are numbers of systematic reviews evaluating the effectiveness of these treatments. However, the overall quality of the evidence has not been quantitatively assessed. The aim of this study is to evaluate the possible biases in the published systematic reviews and determine the treatments with reliable evidence. Methods and analysis: We will perform an umbrella review to identify eligible systematic reviews. A comprehensive literature search will be conducted in MEDLINE, EMBASE, and the Cochrane library for systematic reviews. We will describe the general information such as participants, interventions, outcome measurements, and conclusion. Additionally, the heterogeneity and inconsistency between trials will be assessed by the I 2 statistical test and Cochrane Q test. We will assess risk of bias, and summarize the strength evidence. Conclusion: The umbrella reviews will assess the reliability of the evidence so that doctors and patients can make better medical choices. PROSPERO registration number: CRD42018109597